SARS-CoV2 infects pancreatic beta cells in vivo and induces cellular and subcellular disruptions that reflect beta cell dysfunction
Authors:
- Katelyn MilletteKMKatelyn Millette
- Janielle CualaJCJanielle Cuala
- Peiyu WangPWPeiyu Wang
- Carolyn MarksCMCarolyn Marks
- Veronica WooVWVeronica Woo
- Maya HayunMHMaya Hayun
- Harsimar KangHKHarsimar Kang
- Scott FraserSFScott Fraser
Preprint
- 20 July 2021
- preprint
- Published by Springer Nature in Research Square
Abstract
Increasing evidence of new-onset diabetes during the COVID19 pandemic indicates that the SARS-CoV2 virus may drive beta-cell dysfunction leading to diabetes, but it is unclear if it is a primary or secondary effect. Here, we present evidence of SARS-CoV-2 infection of pancreatic beta cells in vivo using a robust and reproducible non-human primates model of mild to moderate COVID19 pathogenesis. Pancreas from SARS-CoV-2 infected subjects were positive for the SARS-CoV2 spike protein by immunohistochemistry and structures indicative of viral replication were evident by electron microscopy. Total beta cell area was decreased in SARS-CoV-2-infected pancreas, attributable to beta cell atrophy. Beta cell granularity was decreased. These histologic phenotypes persisted beyond the duration of the clinical disease course. Detailed electron microscopy of SARS-CoV-2 infected beta-cells revealed ultrastructural hallmarks of beta cell stress that are seen in islets of patients with Type 2 diabetes, including disrupted mitochondria and dilated endoplasmic reticulum. To assess the metabolic status of beta cells from SARS-CoV-2-infected subjects, we used fluorescence life-time imaging to measure the ratio of free and bound NADH as a surrogate of glycolytic and oxidative metabolism. We report an increase in free NADH levels, suggesting that beta cells from SARS-CoV-2-infected subjects adopt a more glycolytic metabolic profile. Taken together, we conclude that SARS-CoV-2 infection induces beta cell stress that may compromise beta-cell function beyond the duration of the disease course. This raises the possibility that the beta cell stress and injury may have clinical implications of the long-term future health of patients that have recovered from COVID19.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progressionPLOS Pathogens, 2020
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent AxisCell Metabolism, 2020
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaquesScience, 2020
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and OrganoidsCell Stem Cell, 2020
- Diabetes and COVID-19: a major challenge in pandemic period?2020
- Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cellsNature Communications, 2019
- Evidence of β-Cell Dedifferentiation in Human Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2016
- Quantification of β-cell insulin secretory function using a graded glucose infusion with C-peptide deconvolution in dysmetabolic, and diabetic cynomolgus monkeysDiabetology & Metabolic Syndrome, 2013
- Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell FailureCell, 2012
- Necrosis Is the Predominant Type of Islet Cell Death During Development of Insulin-Dependent Diabetes Mellitus in BB RatsLaboratory Investigation, 2003